Beruflich Dokumente
Kultur Dokumente
Business Management
CORE COMMUNICATIONS
INDUSTRY SOLUTIONS
Ageing Demographic
Patients Empowered
System Inefficiencies
TREATMENT
MONITORING
Optimising prevention and compliance keeps patients out of more expensive curative loops
Increasing detection and diagnostic rates through connected interfaces, reducing the demand on providers
Increasing access to quality medicines and treatment and enabling higher quality of care
Improving system management and efficiencies (data veracity, speed of capture, transparency).
How we deliver it
Cloud solution integrated into existing processes Analyze and manage existing processes communication Event driven communication platforms Device and network agnostic service Software as a service Quick set-up
Sanofi Aventis (SA) have 4 000 patients enrolled in their existing PSP (education, compliance, direct support). Enable Sanofi-Aventis to increase their market share in the private sector in South Africa for their range of diabetes products:
Increase patient compliance and client retention Increase workforce efficiency Increase access for all stakeholders to decision support and risk management functions
Cost effective
Huge pressure on healthcare funders globally
Scale
Scale beyond borders & numbers: cross cutting platforms
Sustainability
Spans the continuum: Mobile for Good
Partnerships
Vital in the Public Health Arena and increasingly so in Private
Platforms
Point solutions are not strategic; idea is to own the provider patient channel end to end.
Personal perspective
mHealth is not as sexy as it seems?
Well intentioned NGOs, Entrepreneurs etc. have created high expectations but have largely failed Industry is either unaware or nave about the benefits: sales cycles are extended We have not proven, conclusively that it works (anecdotal data prevails) There is very little conclusive cost benefit data This is not a selling job (we dont yet have all the products the markets need (at the moment), its still at the artistry stage
The pay off from mHealth and other VF verticals demands a long term view
Patient-reported treatment outcome system for users of their immunoglobulin treatments in the UK